Richard Christopher
Chief Executive Officer, Director · Lexaria Bioscience Corp.
- 2024
- Jul 30, 2025
- 3
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Richard Christopher. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Bunka - $25K in LEXX purchases and sales on record
- John Martin Docherty - $5K in LEXX purchases and sales on record
- William Edward McKechnie - $5K in LEXX purchases and sales on record
- Vanessa Carle - $683 in LEXX purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard Christopher?
Richard Christopher is a corporate insider, tracked as Chief Executive Officer, Director of Lexaria Bioscience Corp. (LEXX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Richard Christopher last file a Form 4?
The most recent primary Form 4 on record is dated 30 July 2025, one of 3 filings going back to 2024.
Has Richard Christopher been buying or selling stock?
Recorded transactions: 3 open-market purchases ($132K) and 0 open-market sales across all tracked filings.
